海波重科(300517.SZ):簽訂8407.39萬元合同
格隆匯 8 月 17日丨海波重科(300517.SZ)公佈,近日,海波重型工程科技股份有限公司(“乙方”)與中交一公局第五工程有限公司(“中交一公局五公司”)簽署2份合同,合同金額合計為2433.65萬元;與中交一公局第五工程有限公司蘇州分公司簽署2份合同,合同金額合計為5973.74萬元。以上合同金額累計為8407.39萬元。
合同的簽訂是公司進一步深入道路橋樑鋼結構製造、安裝領域戰略佈局的重要體現,有利於進一步提升公司在行業內的聲譽和品牌影響力。公司與中交一公局五公司的合作將形成公司新的利潤增長點,為公司今後主營業務的戰略轉型升級夯實基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.